Guerbet SA (EPA: GBT)

France flag France · Delayed Price · Currency is EUR
34.80
+0.55 (1.61%)
Aug 30, 2024, 5:35 PM CET
56.76%
Market Cap 437.71M
Revenue 795.65M
Net Income 23.87M
Shares Out 12.58M
EPS 1.90
PE Ratio 18.34
Forward PE 13.38
Dividend 0.50 (1.44%)
Ex-Dividend Date Jul 1, 2024
Volume 4,213
Open 34.20
Previous Close 34.25
Day's Range 34.20 - 35.10
52-Week Range 15.48 - 40.25
Beta 0.74
Analysts n/a
Price Target n/a
Earnings Date Sep 25, 2024

About Guerbet

Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution; Dotarem, a gadoteric acid-gadoterate meglumine, and Artirem, a gadoteric acid that acts as a contrast agent for MRI, as well as prefilled syringes... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1926
Employees 2,920
Stock Exchange Euronext Paris
Ticker Symbol GBT
Full Company Profile

News

There is no news available yet.